Result: Only 5% of ochronosis patients are associated with phenol containing drug use. The long time gap between development of ochronosis and phenols used may attribute to weak causal relation ... conclude if exogenous…
Peak concentration (Cmax): 2.1 mg/L (after 300mg PO) Around 30% of active drug excreted unchanged in urine Water soluble prodrug of tetracycline (Better oral absorption) PHARMACODYNAMICS Lymecycline ... very well from…
last years, remarkable advances in the development of innovative treatments for EB have been achieved. The strategies include, read-through drugs, cell therapy, tissue bioengineering and gene therapy approaches (viral
BACKGROUND Leprosy is one of the common neuro-paralytic disease in a developing country like India. It reduces functional integrity of the different parts of our body and subsequently ... technique, both the groups are…
Statement of the Problem: Biopharmaâ??s 50-year old drug development model â?? which focuses on products and healthcare providers, rather than patients and health outcomes â?? is failing ... matter most to patients, all…
What is the breakthrough therapy designation application and how is it impacting the global drug development? In 2012, Congress created the breakthrough-therapy designation to expedite the testing and approval…
three important characteristics in developing strategies for the biosimilar. For quality control of the biosimilar production process and product, in-process samples, drug substance and drug product are evaluated
vital to defining critical quality attributes which affect safety, efficacy and quality of drugs. For head to the head comparison; mass spectrometry, capillary electrophoresis and SPR technology were used ... evaluated…
pure drug and marketed formulation. A solid self-Micro emulsifying drug delivery system of olanzapine was developed successfully and demonstrated for improving the dissolution of olanzapine. This may lead
Peak concentration (Cmax): 2.1 mg/L (after 300mg PO) Around 30% of active drug excreted unchanged in urine Water soluble prodrug of tetracycline (Better oral absorption) PHARMACODYNAMICS Lymecycline ... very well from…
last years, remarkable advances in the development of innovative treatments for EB have been achieved. The strategies include, read-through drugs, cell therapy, tissue bioengineering and gene therapy approaches (viral
three important characteristics in developing strategies for the biosimilar. For quality control of the biosimilar production process and product, in-process samples, drug substance and drug product are evaluated
What is the breakthrough therapy designation application and how is it impacting the global drug development? In 2012, Congress created the breakthrough-therapy designation to expedite the testing and approval…
Statement of the Problem: Biopharma’s 50-year old drug development model – which focuses on products and healthcare providers, rather than patients and health outcomes – is failing to meet modern ... matter most to…
identified as three important characteristics in development strategies for biosimilar. For quality control of the biosimilar production process and product, in-process samples, drug substance, and drug product is…
What is the breakthrough therapy designation application and how is it impacting the global drug development? In 2012, Congress created the breakthrough-therapy designation to expedite the testing and approval…
Statement of the Problem: Biopharma’s 50-year old drug development model – which focuses on products and healthcare providers, rather than patients and health outcomes – is failing to meet modern ... matter most to…
Moreover, this talk will highlight how the development of nanoparticles has influenced traditional drug discovery and development. There has been a noted increase in combined nanoparticle – drug approaches but some…
steroidal anti-inflammatory drugs respectively. A simple, rapid, selective and sensitive ultra pressure liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method has been developed and validated for…
last decade, while COPD incidence is witnessing a rapid rise in India and other developing nations. Currently, COPD is the third largest killer affecting an estimated 210 million people. Almost ... early stages. They…
risks is complicated by their relatively low lethal toxicity. In our previous studies, we developed an analytical method for the profiling of classical neurotransmitters and their metabolites ... days. Afterwards, novel…